Segment disclosures

Company overview

Traws Pharma, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 12 retained observations 9 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Single Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=traw:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-312790000 USD20260415Open filing evidence
2025-01-01 – 2025-09-302790000 USD20261116Open filing evidence
2025-04-01 – 2025-06-302733000 USD20260814Open filing evidence
2025-01-01 – 2025-06-302790000 USD20260814Open filing evidence
2025-01-01 – 2025-03-3157000 USD20260515Open filing evidence
2024-01-01 – 2024-12-31226000 USD20260415Open filing evidence
2024-07-01 – 2024-09-3057000 USD20251113Open filing evidence
2024-01-01 – 2024-09-30170000 USD20251113Open filing evidence
2024-04-01 – 2024-06-3057000 USD20250814Open filing evidence
2024-01-01 – 2024-06-30113000 USD20250814Open filing evidence
2024-01-01 – 2024-03-3156000 USD20250515Open filing evidence
2023-01-01 – 2023-12-31226000 USD20250331Open filing evidence